Why Your Child's Prescription Keeps Getting Stronger

Most parents hear the same sentence at the optician every year. The prescription has gone up a bit, that is quite normal at this age, here is a new pair. It is accurate and it is incomplete, and the part that gets left out is the part that can actually be acted on.

What is actually changing

Myopia, or nearsightedness, is usually described as the eye focusing light in front of the retina rather than on it. That is true, but it describes the symptom rather than the cause. In the overwhelming majority of childhood myopia, the reason light lands short is that the eyeball itself has become too long from front to back.

This is called axial elongation, and it is the single most important concept for a parent to understand. A prescription is a measurement of the optical consequence. Axial length is a measurement of the physical change, and it is the physical change that carries the long term risk.

Think of the retina as wallpaper lining the inside of a sphere. If the sphere gets bigger, the wallpaper has to stretch to cover it. A stretched retina is thinner, more fragile and more prone to tearing, and it does not un-stretch when the child stops growing.

Why the final number matters for the rest of their life

This is the part that is rarely explained, and it is why the conversation is worth having early. The risks associated with myopia are not about how thick the glasses are. They track the axial length the eye reaches by adulthood, and they persist for life.

None of that is a reason to panic about a child who needs glasses. It is a reason to treat progression as something worth slowing rather than something to simply keep pace with.

Why standard glasses do not slow it down

Ordinary single vision glasses correct central vision perfectly well. The problem is what they do at the edges.

A standard lens brings light to a sharp focus at the centre of the retina, but in the periphery light lands behind the retinal surface rather than on it. The current understanding is that the eye reads that peripheral signal as an instruction to keep growing longer, chasing the focal point. So the glasses fix today's vision while leaving the growth signal in place.

Myopia control methods all work by changing that peripheral signal, bringing peripheral light to a focus in front of the retina instead of behind it. The growth cue is removed, and elongation slows.

The three approaches with real evidence behind them

Overnight Ortho-K lenses

A custom rigid lens worn only during sleep reshapes the front surface of the cornea, so the child sees clearly all day with nothing on their eyes. The reshaped cornea also produces exactly the peripheral defocus profile that slows elongation, which means one intervention does both jobs.

It suits active children particularly well. No glasses at school, nothing to lose or break, swimming is not a problem, and the handling happens at home at bedtime with a parent present rather than in a school bathroom.

Soft multifocal contact lenses

Specific soft lens designs carry concentric zones of different power that create the same peripheral defocus effect during daytime wear. They are quicker to fit than Ortho-K and cover a wider prescription range.

The trade off is daily handling, which for a younger child means managing lenses away from home.

Low dose atropine drops

One drop at bedtime, at a concentration far below what is used to dilate pupils. The mechanism is not fully understood but the effect on slowing elongation is well documented.

It does not correct vision, so glasses are still worn. It suits younger children not ready for lenses, and it can be combined with a lens based method for children progressing quickly despite one treatment.

What outdoor time actually does

Time outdoors is the only myopia intervention that costs nothing, and it has surprisingly consistent evidence behind it across studies in different countries.

The mechanism appears to be light intensity rather than distance viewing. Outdoor daylight is between ten and a hundred times brighter than indoor lighting even on an overcast day, and that intensity is thought to stimulate retinal dopamine release, which inhibits axial elongation.

Around two hours a day is the figure most consistently associated with benefit. Notably, it does not seem to matter what the child is looking at, so reading a book in the garden still counts. In Phoenix that is easy for most of the year and requires planning around the summer, with early mornings and evenings doing the work.

When to start

As soon as progression is established. Myopia progresses fastest in the first years after onset, which means the earliest intervention captures the most benefit. Children as young as six are treated routinely.

Starting later is still worthwhile. A twelve year old whose prescription is still climbing has several years of progression ahead, and slowing those years still lowers the endpoint. But the arithmetic favours starting early.

What to bring to the appointment

• Previous prescriptions, even from another practice, so the rate of change is visible immediately
• Your child's current glasses
• A note of how much time they spend outdoors on a typical day
• Any family history of myopia, particularly in parents

The assessment records a baseline including axial length measurement, which becomes the reference point for every future comparison. Without a baseline, nobody can tell you whether a treatment is working. With one, the answer is a measurement rather than an opinion.

What the research actually found

It is worth knowing what the evidence base looks like, because myopia control is an area where confident claims outrun the data fairly often.

The strongest results come from trials that measured axial length rather than prescription, because prescription can shift for reasons unrelated to eye growth. Across independent trials of overnight lenses, children treated showed meaningfully less axial elongation over two years than children in single vision glasses. Soft multifocal lens trials and low dose atropine trials report reductions in the same broad range.

What the trials do not show is any method stopping progression. Every published result is a slowing, not a halt. They also show wide individual variation: some children respond strongly, some barely at all, and there is currently no reliable way to predict which a particular child will be before starting.

That is precisely why baseline measurement matters more than any population average. The question that matters is not what happened to the average child in a trial, it is what is happening to your child's eye against its own starting point.

What a first appointment actually involves

Sixty to ninety minutes, most of it measurement rather than conversation.

A full eye health assessment comes first, because a rising prescription occasionally has a cause other than ordinary myopia. Then refraction, often with cycloplegic drops in younger children, because a child's focusing system is powerful enough to mask part of a prescription and produce a reading that is simply wrong.

Corneal topography follows, mapping the front surface of the eye in three dimensions. That map determines whether overnight lenses are an option at all, and it also establishes a baseline for corneal shape.

Finally, axial length. This is the measurement everything afterwards is compared against, and it is the reason the first appointment has value even if you decide to do nothing. Without a baseline, nobody can tell you in two years whether anything worked.

Questions worth asking

• What is my child's axial length now, and what would you expect it to be in a year without treatment?
• Which method do you think suits this particular child, and why that one rather than the others?
• What will we measure at each review, and what would tell us it is not working?
• What happens if we start and my child cannot get on with it?
• What is the realistic total cost over the years we would be doing this?

The answers to those five will tell you a great deal about whether you are in the right place. A practitioner who cannot say what they will measure, or who promises to stop progression rather than slow it, is worth being cautious about.

What parents most often regret

In practice, the regret is almost never about trying something. It is about the years spent updating glasses without anyone mentioning that the trajectory could be influenced at all.

Progression is fastest in the first years after onset, which means the window where intervention achieves most is also the window where families are least likely to have heard of myopia control. A child who starts at seven has considerably more to gain than the same child starting at twelve, and the difference is not recoverable later.